Catalogo dei prodotti della ricerca

RIDOLA, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.744
EU - Europa 1.624
AS - Asia 701
AF - Africa 84
SA - Sud America 29
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.187
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.674
IT - Italia 846
SG - Singapore 311
IN - India 230
SE - Svezia 201
DE - Germania 130
CN - Cina 99
IE - Irlanda 76
FI - Finlandia 75
UA - Ucraina 74
GB - Regno Unito 68
BG - Bulgaria 63
CA - Canada 44
BJ - Benin 35
TG - Togo 32
RO - Romania 19
TR - Turchia 17
AR - Argentina 15
BZ - Belize 15
NL - Olanda 14
CH - Svizzera 12
RU - Federazione Russa 11
HK - Hong Kong 9
KZ - Kazakistan 9
ES - Italia 8
IR - Iran 7
MX - Messico 7
BE - Belgio 6
FR - Francia 6
BR - Brasile 5
DZ - Algeria 5
CO - Colombia 4
KR - Corea 4
TW - Taiwan 4
AU - Australia 3
DK - Danimarca 3
NG - Nigeria 3
PL - Polonia 3
RS - Serbia 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AL - Albania 2
BD - Bangladesh 2
CU - Cuba 2
EC - Ecuador 2
EG - Egitto 2
EU - Europa 2
GT - Guatemala 2
KE - Kenya 2
LT - Lituania 2
PE - Perù 2
SC - Seychelles 2
CL - Cile 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 7.187
Salva come PNG Salva come JPEG
Città #
Fairfield 735
Chandler 386
Ashburn 369
Woodbridge 339
Houston 272
Wilmington 259
Seattle 252
Cambridge 245
Rome 219
Singapore 180
San Paolo di Civitate 149
Princeton 144
New York 119
Ann Arbor 113
Fremont 93
Lawrence 85
Dearborn 84
Boston 80
Stockholm 67
Sofia 63
San Diego 60
Plano 59
Millbury 58
Dublin 56
Beijing 51
Milan 48
San Jose 43
Frankfurt am Main 35
Lomé 32
Andover 30
Fasano 30
Bologna 27
Southend 27
Bremen 24
Ottawa 23
Des Moines 20
Helsinki 20
Jacksonville 20
Santa Clara 19
Norwalk 17
Toronto 17
Belize City 15
Federal 15
London 15
San Mateo 15
Menlo Park 14
Dallas 13
Falls Church 12
Naples 12
Ankara 11
Los Angeles 11
Saint Louis 10
Hong Kong 9
Newtownabbey 9
Ridder 9
Concorezzo 8
Padova 8
Bern 7
Guangzhou 7
Kunming 7
Pomezia 7
Atlanta 6
Boardman 6
Brussels 6
Bühl 6
Catania 6
Cesena 6
Columbus 6
Lappeenranta 6
Nanchang 6
Phoenix 6
Teramo 6
Washington 6
Como 5
Genova 5
Mannheim 5
Mexico City 5
Buffalo 4
Groningen 4
Isola del Liri 4
Jinan 4
Madrid 4
Sacramento 4
Sesto San Giovanni 4
Trieste 4
Verona 4
Villa d'Adda 4
Carlinville 3
Changsha 3
Chicago 3
Colle Di Val D'elsa 3
Hefei 3
Hyderabad 3
Iesi 3
Kilburn 3
Lagos 3
Livorno 3
Mascalucia 3
Muizenberg 3
Odense 3
Totale 5.354
Salva come PNG Salva come JPEG
Nome #
FXR modulators and cholestatic diseases | [Modulatori di FXR e patologie colestatiche] 198
Italian clinical practice guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 141
Transplantation of stem/progenitor cells isolated from human fetal biliary tree into two patients with advanced liver cirrhosis 110
Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: Time to update the guidelines? 108
Evidence of Persistent Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy 107
High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: A case-control study 104
Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice 103
Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial 103
The animal naming test: an easy tool for the assessment of hepatic encephalopathy 102
Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis 102
Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment 97
Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice 96
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology 96
Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt 95
Inflammatory bowel disease nurse specialists for patients on biological therapies: a nationwide Italian survey 95
Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients 94
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial 94
Cirrhotic patients are at risk for health care-associated bacterial infections. 93
A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy 93
The staging of gastritis with the olga system in the italian setting. histological features and gastric cancer risk 91
Can an incomplete stent expansion modulate the effects of TIPS? 90
Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis 86
Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine 85
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 84
Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice 81
Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients 80
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (tips): PTFE-covered stent grafts versus bare stents 80
VIDEOCAPSULE ENDOSCOPY IN PATIENTS WITH PORTAL HYPERTENSION: SMALL BOWEL FINDINGS BEFORE AND FOLLOWING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT 79
Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents. A systematic review of randomized controlled trials 78
New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin 78
Prediction of hepatic encephalopathy: Why disregard well-known risk factors? 78
MELD, PROTEIN MALNUTRITION AND PREVIOUS INFECTIONS ARE PREDICTORS OF BACTERIAL INFECTIONS AND SEPSIS IN CIRRHOTIC PATIENTS 76
Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS 76
PTFE-covered stent-grafts for tips procedure: One-year patency and clinical results 75
Cholangiocytes: Cell transplantation 75
Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis? 74
Hepatic encephalopathy therapy: An overview. 73
Association between diverticulosis and colonic neoplastic lesions in individuals with a positive faecal immunochemical test 72
Erectile dysfunction in patients with liver cirrhosis 70
PPIs in cirrhosis: more evidences for a careful prescription! 68
The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS 68
Safety of cold polypectomy for <10mm polyps at colonoscopy: A prospective multicenter study 68
MELD, PROTEIN MALNUTRITION AND PREVIOUS INFECTIONS ARE PREDICTORS OF BACTERIAL INFECTIONS AND SEPSIS IN CIRRHOTIC PATIENTS 67
Prevention of hepatic encephalopathy after porto-systemic shunt 67
First-line therapies for Helicobacter pylori eradication: A critical reappraisal of updated guidelines 67
Accurate assessment of cardiac function and myocardial fibrosis in liver cirrhosis by contrast-enhanced cardiac magnetic resonance 67
Quality of life in patients with minimal hepatic encephalopathy 66
Prevalence of lesions detected at upper endoscopy: An Italian survey 64
Vitamin D deficiency in patients with either rheumatic diseases or inflammatory bowel diseases on biologic therapy 64
Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms 64
The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies 63
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: still a major problem. 61
Improving the inhibitory control task to detect minimal hepatic encephalopathy 59
Endoscopic findings and psychometric abnormalities: what is the relationship in upper endoscopic outpatients? 59
Ammonia and the muscle: an emerging point of view on hepatic encephalopathy 59
Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review. 58
How to design a multicenter clinical trial in hepatic encephalopathy 58
Sex differences in response to TNF-Inhibiting drugs in patients with spondyloarthropathies or inflammatory bowel diseases 57
Emerging drugs for hepatic encephalopathy 56
Sarcopenia and cognitive impairment in liver cirrhosis: a viewpoint on the clinical impact of minimal hepatic encephalopathy 56
Is faecal-immunochemical test useful in patients with iron deficiency anaemia and without overt bleeding? 56
VALIDATION AND PROGNOSTIC VALUE OF SIMPLIFIED PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE (SPHES) FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 55
Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19. A multicentric prospective evaluation 55
PTFE-covered stent-grafts for TIPS procedure: One-year patency and clinical results 54
Radiological Intervention for Shunt Related Encephalopathy 53
Simple tools for complex syndromes: A three-level difficulty test for hepatic encephalopathy 52
High prevalence of spontaneous porto-systemic shunts in cirrhotic patients with recurrent hepatic encephalopathy: A case control study 52
Relevance of spontaneous portosystemic shunts detected with CT in patients with cirrhosis 51
Hepatic encephalopathy is more frequent and severe after transjugular intrahepatic portosystemic shunt (TIPS) with PTFE-covered stent-grafts 50
Small hepatic veins Budd-Chiari syndrome and paroxysmal nocturnal hemoglobinuria - The association of two rare entities: a case report 50
Rifaximin therapy and hepatic encephalopathy: Pros and cons. 49
Helicobacter pylori Might Contribute to Persistent Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy Reply 48
Quality of colonoscopy in an emerging country: A prospective, multicentre study in Russia 48
Risk factors for hepatic encephalopathy and mortality in cirrhosis: the role of cognitive impairment, muscle alterations and shunts: predictors of HE 48
Peripheral and Splanchnic Indole and Oxindole Levels in Cirrhotic Patients: A Study on the Pathophysiology of Hepatic Encephalopathy. 47
Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma 46
Appropriateness of the Indication for Colonoscopy Is the Endoscopist the 'Gold Standard'? 46
Hepatic encephalopathy: diagnosis and management 45
Minimal hepatic encephalopathy and sleep disorders in patients with cirrhosis. Which comes first? 44
Comparison between lactitol, rifaximin and no treatment in the prevention of hepatic encephalopathy after transjugular intrahepatic porto-systemic shunt (TIPS): Results of a randomized controlled trial 43
Glaucoma and Helicobacter pylori: Eyes wide shut? 43
Natural history and management of refractory benign esophageal strictures 42
Risk of falls in patients with cirrhosis evaluated by timed up and go test. Does muscle or brain matter more? 42
High prevalence of vitamin D deficiency and insufficiency in patients with rheumatic diseases 41
Emerging therapies for advanced cholangiocarcinoma. An updated literature review 40
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 39
Carotid artery intima-media thickness in patients with autoimmune connective tissue diseases: A case-control study 39
Physiopathology and treatment of anastomotic ulcer: An emerging pathology? 39
Endoscopic mucosal resection and endoscopic submucosal dissection for colorectal lesions: A systematic review 38
Letters to the editor 38
A prospective randomized study comparing 25-G and 22-G needles of a new platform for endoscopic ultrasound-guided fine needle aspiration of solid masses 38
Inflammatory and neoplastic cholangiopathies [Colangiopatie infiammatorie e neoplastiche] 38
A challenging diagnosis of jejunal adenocarcinoma in a celiac patient: Case report and systematic review of the literature 37
Helicobacter pylori eradication for hepatic encephalopathy treatment: The ideal study is still lacking 37
Cognitive impairement in non-cirrhotic portal hypertension: highlights on physiopathology, diagnosis and management 37
Porto-sinusoidal vascular disorder (PSVD): application of new diagnostic criteria in a multicenter cohort of patients 36
Clinical management of type C hepatic encephalopathy 36
Psoriatic arthritis mutilans: Case series and literature review 35
Old and new precipitants in hepatic encephalopathy: a new look at a field in continuous evolution 34
Rheumatoid arthritis and cardiovascular risk: Between lights and shadows 34
Totale 6.683
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.639
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.639
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.114 0 0 24 45 110 327 174 134 139 81 51 29
2020/20211.325 58 35 422 213 27 59 56 90 74 192 50 49
2021/20221.387 24 41 111 87 190 49 54 123 152 79 251 226
2022/20231.579 270 314 111 187 124 154 25 88 193 24 44 45
2023/20241.124 58 134 70 82 123 239 62 65 12 94 122 63
2024/2025345 139 122 84 0 0 0 0 0 0 0 0 0
Totale 7.735